Immunotherapy & Oncology
Cancer treatment has moved from poisoning dividing cells towards directing the immune system at the tumour, and towards drugs that carry their payload only to cancerous tissue. It absorbs more drug development spending than any other area.
388 stocks
New
Increased
Maintained
Reduced
Closed
Funds Holding
6,122
Funds Holding Change
+478
Funds Holding Growth
+8%
Value
$1.77T
Holding in Top 10
918
Top 10 Change
+127
Top 10 Growth
+16%
Value Growth
+17%
New
719
Increased
2,618
Reduced
2,474
Closed
112
Capital Inflow
$110B
Capital Outflow
$46.8B
Net Capital Flow
+$62.8B
Capital Flow Change
+$94.2B
Calls
$24.9B
Puts
$22.4B
Net Calls
+$2.46B
Put/Call Ratio
0.9